© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
720193 |
As an accredited N-Methyl-2-Bromobenzylamine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive N-Methyl-2-Bromobenzylamine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Every lab worker remembers the first time they cracked open a bottle of N-Methyl-2-Bromobenzylamine. The label probably looked long and imposing, but there’s real value behind that mouthful of syllables. In the world of specialty chemicals, few substances provide the mix of stability and reactivity you get from this compound. It's more than just another flask on a bench; it stands out for people looking to build complex molecules in pharmaceuticals and organic synthesis work. What makes it tick? It’s that amine at the end, paired with a bromine atom—small structural quirks that shift its personality in experiments. Sometimes these subtle differences make or break a process, affecting how easily a reaction can be tuned or what impurities might show up.
A lot of researchers are forever searching for shortcuts—a way to cut out extra steps or clean up their reactions. N-Methyl-2-Bromobenzylamine offers a jumpstart, delivering its functional groups right where they matter for further transformations. It's often chosen when you need nucleophilicity balanced against stability, carving out a niche somewhere between too reactive and stubbornly inert. I’ve seen bench chemists look for amino building-blocks that don’t immediately decompose or tie up every electrophile in sight. This product listens. Its molecular structure makes it a smart intermediate for preparing heterocycles, aryl amines, and more, helping laboratories reach targets in fewer steps.
What you notice in the bottle is a colorless to pale yellow liquid, a bit viscous and unmistakably pungent. It’s not the sort of compound you forget after your first encounter. The molecular formula combines a benzyl backbone with a methylamino group and bromine substitution at the ortho position. This arrangement directs reactivity in ways that matter during synthesis: the bromine acts as a useful anchor point for cross-coupling reactions, while the amine functions as a nucleophile or a buffer for forming new bonds. These characteristics let it slip into Suzuki, Buchwald-Hartwig, and other classic organic transformations without skipping a beat.
I remember standing at the glovebox, thinking about compatibility. Some similar amines bring headaches—immediate hydrolysis, nasty byproducts, or volatility issues. By contrast, N-Methyl-2-Bromobenzylamine plays well when handled properly. It typically boasts a boiling point just high enough to avoid constant evaporation but low enough to permit distillation for purification. Thanks to this balance, labs don’t need exotic equipment just to store or prepare it for reactions.
Researchers in medicinal chemistry keep raising the bar. Drug discovery teams look for building-blocks that allow them to maintain design flexibility. N-Methyl-2-Bromobenzylamine often finds its way onto synthetic routes because its amine group stays available for modifications. Whether designing kinase inhibitors or tailored ligands, this compound delivers that starter scaffold with room for elaboration. The bromine atom, meanwhile, sets up for selective cross-coupling, expanding the chemist’s toolkit. It’s not just about stringing together bonds; it’s about making sure every transformation proceeds cleanly, with minimal side-products.
Some analogs without methyl substitution feel rigid or less tractable during substitutions. This methyl group grants just enough bulk to influence selectivity, smoothing unpredictable outcomes in the final product. Synthetic chemists I’ve worked with appreciate products that shave precious hours from purification steps, and this one delivers in that respect. The reduction in byproduct formation often makes downstream work more efficient, cutting costs and reducing waste—factors that matter in both research-intensive settings and at scale.
Within the broader world of alkylbenzylamines, minor tweaks can dramatically reshape how a molecule behaves. I’ve watched colleagues get tripped up swapping out methyl groups or bromine positions, only to see their reactions stall, or impurities creep in. Take the comparison with regular benzylamine, for instance. Standard benzylamine, while useful, lacks the halogen handle for palladium-catalyzed coupling. If you’re working toward biaryl structures, N-Methyl-2-Bromobenzylamine provides an easy point of entry, bypassing cumbersome protecting group strategies.
Consider also the differences from N-methyl-3-bromobenzylamine or N-ethyl variants. The placement of the bromine on the ring dictates steric and electronic effects, steering substitution patterns once you’re deep into a synthesis. Ortho substitution in the 2-position can pull electron density, sometimes speeding up desired reactions or even blocking side ones. That saves frustration and disappointment. The methyl group adjacent to the nitrogen helps in modulating basicity, giving the chemist more control during acid-base sensitive steps—a subtlety that’s often appreciated in multistep processes where stability can’t be taken for granted.
A conversation about synthetic intermediates isn’t complete without addressing safety. Like many arylamines, N-Methyl-2-Bromobenzylamine comes with precautions. Think gloves, goggles, and a well-ventilated hood. This isn’t the sort of liquid you splash around with abandon. In my experience, careful planning and standard protective equipment eliminate most risks. That lets researchers focus on the chemistry, not on hazard mitigation.
Material Safety Data Sheets outline standard protocols for storage—cool, dry places, containers tightly sealed. Sensible measures and responsible storage practices pay off, not just in avoiding accidental exposures but also by preserving the material’s quality over long periods.
Each batch of N-Methyl-2-Bromobenzylamine earns its stripes by passing purity benchmarks. Experienced buyers keep an eye out for clear GC-MS and NMR profiles, clean of extraneous signals. Commercial supplies typically land at purities above 98%, a standard that grows more important when working with reactions sensitive to trace metals or organic contaminants. I’ve seen projects derail over fractional percentages of unwanted isomers—this isn’t a theoretical concern for teams chasing new patents or regulatory clearance.
Specs also cover solvent compatibility and packaging. Every seasoned chemist has seen what humidity or poorly sealed containers can do to delicate reagents. Suppliers know their customers rely on consistent packaging—glass bottles, lined caps, and secondary containment to guard both the product and anyone handling it. Good product stewardship shows up in small ways: clear lot numbers, shipment tracking, and documentation that matches analytical tests run internally in most research labs.
Anyone in the business of making or buying synthetic intermediates learns to navigate a crowded supply chain. Knock-off batches and ambiguous provenance are real hazards. I’ve depended on samples with full Certificate of Analysis, and I’ve wasted entire weeks chasing contaminants introduced by poor production protocols. N-Methyl-2-Bromobenzylamine’s applications demand the kind of quality guarantee that reputable suppliers provide. Every shipment should include analytical data—HPLC, MS, and NMR spectra—ensuring it meets stated specifications.
By purchasing from vetted suppliers, researchers cut down on project delays caused by questionable quality. Consistency matters most to scale-up teams translating lab work to kilo quantities for clinical supply or early manufacturing. This is where cost-saving tricks prove shortsighted; a faulty batch ruins more than just an experiment.
Drug discovery isn’t a linear journey—ideas ricochet from whiteboard sketches to bench-scale experiments, then on to candidate evaluation. N-Methyl-2-Bromobenzylamine helps keep that pipeline flowing. Its structural features allow for rapid insertion into library synthesis, underpinning lead optimization for new therapies. Medicinal chemists benefit most from reagents that don’t introduce noise into assays or complicate purification.
Speed counts, but so does reliability. When designing analogs or optimizing SAR (structure–activity relationships), you rely on intermediates that won’t break down unexpectedly during handling. In my experience, knowing your amine won't take off during a key workup gives needed peace of mind, particularly when juggling a busy project load. Simpler workups mean more time for creative thinking, not damage control.
Today, environmental stewardship isn’t just marketing—it’s part of running a responsible laboratory. Intermediate chemicals like N-Methyl-2-Bromobenzylamine raise questions about waste and life cycle management, especially in larger operations. Responsible practitioners avoid venting vapors or flushing residues into municipal systems. Instead, they use approved disposal routes, protecting both workers and local communities.
The industry trend has moved toward greener solvents and techniques. Some research groups are experimenting with less hazardous coupling partners, reducing the burden of organic halides during reaction development. Making thoughtful choices at the intermediate stage—selecting compounds with high conversion rates and minimal byproducts—keeps the environmental footprint in check. The brominated amine, in this context, stands as a manageable entry point rather than a problematic exhaust stream.
One reality of lab work: things go sideways without notice. Even a dependable intermediate can yield surprises if protocols drift. I’ve learned that extra attention during the set-up—ensuring correct solvent choice, dry atmosphere, and fresh catalyst—makes all the difference. Some underestimate the impact of leftover water or cross-contamination from common glassware. Purity drops, or yields slip. With N-Methyl-2-Bromobenzylamine, reproducibility improves significantly when you stick to established guidelines and check every reagent ahead of time.
Regular calibration of analytical equipment and keeping thorough records avoids confusion between similar-sounding compounds or mislabeling. Team communication pays off too. I’ve seen researchers save time by circulating updates on any anomalies—cloudiness in solution, odd spectral peaks, or subtle changes in viscosity that suggest shelf-life limits might be approaching. These daily habits foster a safer, more productive atmosphere.
Chemists are spoiled for choice among arylamines, but not all deliver the right mix of reactivity and manageability. A pure N-methyl amine offers a balance—not so volatile that it evaporates away during handling, but reactive enough for electrophilic aromatic substitution. The bromine substituent opens several synthetic doors, providing a direct path to more elaborate frameworks used in drug candidates, dyes, and specialty polymers.
A colleague once tried a similar synthesis with an unsubstituted benzylamine. The product mix proved more challenging to separate, and the lack of a leaving group turned cross-coupling into a headache. Switching to N-Methyl-2-Bromobenzylamine made cleanup neater; column chromatography was less grueling, and yields respected project timelines. These moments build confidence in the decision to invest in the right intermediate up front.
The jump from lab scale to pilot plant throws up fresh challenges. Not every amine makes the leap well. You need a supplier who can offer technical support and consistently meet your batch sizes. N-Methyl-2-Bromobenzylamine, having found its niche in route scouting for scalable syntheses, aligns well with current standards for GMP-compliant manufacturing. I’ve seen teams transition formulation batches, benefitting from the amine’s stability and clear documentation.
Quality assurance isn’t just for audits. Internal QC teams demand certificate data that match their in-house tests; mismatches slow down tech transfer and erode trust in supply chains. Smart firms keep an updated database of historical data for intermediates like this, making it easier to troubleshoot unexpected deviations or answer questions from regulatory agencies during inspections.
Academic research groups and industry teams alike have embraced multipurpose intermediates to stretch grant funding and accelerate cycles of experimentation. N-Methyl-2-Bromobenzylamine, due to its versatility, shows up on multiple research plans: from fragment-based drug discovery to polymer chemistry projects focusing on advanced materials. It acts as a reliable point for diversification, letting chemists tack on new fragments or unlock alternative pathways unavailable with less adaptable building blocks.
Students and postdocs appreciate products that let them move forward without revisiting the basics. There’s value in an intermediate you can trust to behave predictably—saving precious time for creativity or hypothesis testing rather than troubleshooting. One way to foster that kind of progress involves investing in reagents that punch above their weight—N-Methyl-2-Bromobenzylamine fits that description by design.
Even the most reliable products reveal blind spots under stress. Some users express a wish for more comprehensive data on long-term storage and degradation pathways. Detailed stability studies, including photodegradation and byproduct profiling, would enhance confidence—especially for groups working on sensitive therapeutics destined for lengthy registration processes.
There’s also an ongoing conversation around packaging sizes and delivery formats. Projects often operate at very different scales, from milligram screens to multi-gram runs. Flexibility here would help both academic and industrial users stay nimble, reducing overstock waste and making procurement more straightforward.
Better documentation—real spectra, clear descriptions of lot analysis, shelf-life studies—would let smaller teams compete more easily with big players who have internal analytic firepower. While reputable suppliers have made great strides, this is one product category where additional transparency would pay real dividends.
Responsible stewardship of lab chemicals prompts attention beyond technical and economic concerns. Intermediates like N-Methyl-2-Bromobenzylamine, because of their structural features, may attract scrutiny under regulatory frameworks focused on controlled substances or environmental release. Research teams committed to best practices keep up with the evolving landscape of compliance and ethical risk. This includes registering use as required, securing inventory, and cooperating fully with oversight efforts.
Practical ethics also show up in everyday choices. Sharing best practices on safe use, disposal, and spill response supports both workplace safety and wider community health. New entrants to chemical research benefit from mentorship and clear communication about the expectations tied to complex building-blocks. It’s not enough for a product to perform well in a flask; it should enable responsible, reproducible science.
N-Methyl-2-Bromobenzylamine sits inside a class of compounds that have shaped modern organic synthesis. Its dependable performance and subtle, tunable reactivity have earned it a spotlight among synthetic intermediates. Whether supporting drug design, helping new catalysts prove their worth, or serving as a bridge to advanced materials, it rewards scientists willing to invest in thoughtful experimentation.
A good building block doesn’t just fill an order or round out a catalog—it advances projects and creates opportunities. At every stage—design, sourcing, handling, and disposal—the choices made around intermediates like this shape not just the experiment but the future of chemistry. A transparent supply chain and an engaged, informed user base help push the boundaries of what’s possible with each new batch uncapped in the lab.
